Swiss Life Asset Management’s Zimmer Biomet ZBH Stock Holding History

Swiss Life Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.36M	Buy	50,701 +6,786	+15%	+$595K	0.02%	482
2026 Q1	$3.97M	Buy	43,915 +2,381	+6%	+$218K	0.02%	447
2025 Q4	$3.73M	Buy	41,534 +2,303	+6%	+$218K	0.02%	465
2025 Q3	$3.86M	Buy	39,231 +5,905	+18%	+$585K	0.02%	458
2025 Q2	$3.04M	Sell	33,326 -1,071	-3%	-$104K	0.02%	481
2025 Q1	$3.89M	Buy	34,397 +8,233	+31%	+$881K	0.03%	378
2024 Q4	$2.76M	Buy	26,164 +5,956	+29%	+$639K	0.02%	421
2024 Q3	$2.18M	Sell	20,208 -49,614	-71%	-$5.41M	0.02%	369
2024 Q2	$7.58M	Buy	69,822 +52,514	+303%	+$6.19M	0.09%	199
2024 Q1	$2.28M	Sell	17,308 -14,697	-46%	-$1.84M	0.03%	318
2023 Q4	$3.9M	Sell	32,005 -7,066	-18%	-$788K	0.05%	357
2023 Q3	$4.38M	Sell	39,071 -57,306	-59%	-$7.28M	0.07%	314
2023 Q2	$14M	Buy	96,377 +15,362	+19%	+$2.09M	0.21%	112
2023 Q1	$10.5M	Buy	+81,015	New	+$10.2M	0.16%	166
2022 Q2	–	Sell	-9,212	Closed	-$1.18M	–	672
2022 Q1	$1.18M	Buy	9,212 +6,333	+220%	+$763K	0.02%	458
2021 Q4	$356K	Hold	2,879	–	–	﹤0.01%	526
2021 Q3	$408K	Buy	+2,879	New	+$424K	0.01%	514
2021 Q2	–	Sell	-24,057	Closed	-$3.74M	–	552
2021 Q1	$3.74M	Buy	24,057 +138	+0.6%	+$21.4K	0.05%	357
2020 Q4	$3.58M	Buy	23,919 +21,692	+974%	+$3.06M	0.05%	359
2020 Q3	$294K	Hold	2,227	–	–	﹤0.01%	451
2020 Q2	$258K	Hold	2,227	–	–	﹤0.01%	480
2020 Q1	$219K	Sell	2,227 -216	-9%	-$28.3K	﹤0.01%	482
2019 Q4	$355K	Hold	2,443	–	–	0.01%	470
2019 Q3	$326K	Hold	2,443	–	–	﹤0.01%	481
2019 Q2	$279K	Hold	2,443	–	–	﹤0.01%	512
2019 Q1	$303K	Buy	+2,443	New	+$278K	﹤0.01%	467
2018 Q4	–	Sell	-8,659	Closed	-$1.11M	–	479
2018 Q3	$1.11M	Buy	8,659 +4,688	+118%	+$557K	0.01%	381
2018 Q2	$430K	Buy	3,971 +264	+7%	+$28.7K	0.01%	451
2018 Q1	$392K	Sell	3,707 -9,676	-72%	-$1.12M	0.01%	431
2017 Q4	$1.57M	Buy	+13,383	New	+$1.51M	0.04%	256
2017 Q1	–	Sell	-5,639	Closed	-$565K	–	523
2016 Q4	$565K	Sell	5,639 -1,624	-22%	-$174K	0.02%	341
2016 Q3	$915K	Buy	+7,263	New	+$897K	0.03%	243
2015 Q3	–	Sell	-1,898	Closed	-$201K	–	353
2015 Q2	$201K	Sell	1,898 -2,274	-55%	-$252K	0.01%	280
2015 Q1	$476K	Buy	+4,172	New	+$476K	0.02%	184

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Swiss Life Asset Management's ZBH Position: Q2 2026 in Review

Swiss Life Asset Management increased its Zimmer Biomet (ZBH) stake by 15% in Q2 2026, buying an estimated $595K and bringing the position to 50,701 shares worth $4.36M. The position accounts for 0.02% of the portfolio, ranked #482.

Swiss Life Asset Management first reported a position in ZBH in Q1 2015 and has held it in 34 quarters since. The position peaked at $14M in Q2 2023. 645 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Swiss Life Asset Management held 50,701 shares of Zimmer Biomet worth $4.36M as of Q2 2026.
Swiss Life Asset Management bought 6,786 Zimmer Biomet shares in Q2 2026, an estimated $595K.
Zimmer Biomet made up 0.02% of Swiss Life Asset Management's portfolio in Q2 2026, its #482 holding.
Swiss Life Asset Management first reported a position in Zimmer Biomet in Q1 2015 and has held it in 34 quarters since.
Swiss Life Asset Management's Zimmer Biomet position peaked at $14M in Q2 2023.
645 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.